Johnson & Johnson is normally a good buy for its dividend and the stability it offers. Over the past five years, however, the ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...

An estimated 21 million American adults suffer from clinical depression. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...

In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Just a two-year-old when his family moved to Chicago from Mississippi during the Great Depression, Johnson had recently opened a gleaming new 30,000 sq. ft. manufacturing facility on two acres of ...

Donald Trump’s tariff war is too much for his otherwise steadfast ally Senator Ron Johnson, who compared the decision to ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.

Winter depression can take a toll on your mind and body. Local health experts say depression is something you should take seriously. Jessica Bowman speaks with a psychiatric nurse practitioner about ...